KN
Knowles Corp
Next earnings Jul 22, 2026 · consensus $0.31 EPS, $162M rev
Last earnings +2.4% on 2026-04-23
$40.05
▼ -1.81%$40.05▲ +128.60%
over 1Y
L $17.52EODHDH $42.80
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-1.8%
1W-6.4%
1M+6.5%
3M+57.4%
YTD+82.5%
1Y+128.6%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Buy
Genuine pivot to defense/medtech is working, but 80x P/E on 5.7% ROE leaves no margin for execution slip-ups.
Revenue $593M · FY2025
The read
Middling fundamentals and a rich price (~53% above fair value) leave little margin of safety — a wait-and-see.
Knowles is two years into a deliberate transformation into a 'premier industrial technology company' — the May 2025 investor day and the December 2024 divestiture of the Consumer MEMS Microphones business to Syntiant confirm management has decisively walked away from commodity consumer audio. The remaining PD (capacitors, RF filters) and MSA (balanced armature speakers, hearing-health microphones) segments target defense, medtech, industrial and electrification/energy — end markets with better margin structure and longer design cycles. The numbers corroborate the narrative: FY2025 revenue grew 7.2% to $593M, operating income jumped 35.7% to $70.3M, gross margin held a respectable 43.2%, and diluted EPS more than doubled to $0.50. The balance sheet is sound — long-term debt down 14.9% to $114M, no current debt, $776M equity — and management is shrinking the float, repurchasing $65M of stock (+21% YoY) while shares outstanding fell 3.1%.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $868M | $479M | $457M | $554M | $593M |
| Gross profit | $360M | $227M | $204M | $235M | $256M |
| Operating income | $116M | $90.8M | $43.4M | $51.8M | $70.3M |
| Net income | $150M | -$430M | $72.4M | -$238M | $44.2M |
| Diluted EPS | $1.59 | -$4.63 | $0.79 | -$2.64 | $0.50 |
| Net margin | 17.3% | -89.8% | 15.8% | -43.0% | 7.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$3.46B
EV / EBITDA32.5
EV / Sales5.8
EV / FCF—
P / FCF—
PEG (trailing)0.68
Earnings yield1.3%
FCF yield—
Quality & risk
ROIC (est.)6.2%
Free cash flow—
Total debt$114M
Net cash-$59.8M
Piotroski F-Score7/7
Capital returns
Buyback yield1.9%
Dividend yield (est.)—
Shareholder yield1.9%
Shares Δ YoY-3.1%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRecent disclosure tone has been improving.
- 8-K Shareholder vote2026-04-29
Annual meeting vote results (Item 5.07): director slate and routine proposals
- 10-Q Quarterly report2026-04-28
Q1'26 10-Q: industrial-tech transformation progressing post-CMM divestiture
- 8-K Earnings results2026-04-23
Q1'26 earnings release; continues post-divestiture margin recovery trend
- DEF 14A Proxy statement2026-03-11
Proxy: routine director/say-on-pay vote; no governance red flags disclosed
- 8-K Officer / director change2026-02-20
Executive officer change (5.02); leadership transition disclosed
- 10-K Annual report2026-02-09
FY25 revenue $593M +7%, op income +36%, $65M buybacks; medtech/defense pivot
- 8-K Earnings results2026-02-05
Q4'25 earnings: revenue $593M (+7%), EPS $0.50, net income more than doubled
- 10-Q Quarterly report2025-10-28
Q3'25 10-Q showed improving margins from PD/MSA mix shift
- 8-K Earnings results2025-10-23
Q3'25 earnings release; sustained YoY revenue and margin improvement
Recent filings
all on EDGAR ↗4Period ending 2026-05-272026-05-29open ↗SDFiling2026-05-28open ↗144Filing2026-05-27open ↗4Period ending 2026-05-132026-05-14open ↗4Period ending 2026-05-052026-05-07open ↗144Filing2026-05-05open ↗144Filing2026-05-05open ↗144Filing2026-05-01open ↗4Period ending 2026-04-302026-04-30open ↗144Filing2026-04-30open ↗SCHEDULE 13GFiling2026-04-30open ↗4Period ending 2026-02-032026-04-29open ↗
Frequently asked
- Is Knowles Corp (KN) a buy?
- KN currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Genuine pivot to defense/medtech is working, but 80x P/E on 5.7% ROE leaves no margin for execution slip-ups.
- What is KN's fair value?
- A Modified-Graham model based on KN's SEC fundamentals estimates a fair value of about $18.68. It is an estimate from reported earnings, not a price target.
- Is KN overvalued or undervalued?
- Against a Modified-Graham fair-value estimate, KN currently appears overvalued relative to its SEC-grounded earnings power.
- What is Knowles Corp's quality score?
- KN scores 64.56862745098039/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001587523, latest 10-Q filed 2026-04-28) · EODHD · analysis by claude-code · as of 6/25/2026, 1:34:55 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.